Antibody-oligonucleotide conjugates: design principles, intracellular delivery, and translational opportunities
{{output}}
Antibody-oligonucleotide conjugates (AOCs) have emerged as a promising therapeutic platform that integrates the targeting capability of antibodies with the gene-regulatory potential of oligonucleotide payloads. By enabling cell or tissue selective delivery, AO... ...